Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29362108 | 1.00 | PRKCA (0.43) | PRKCATK2 | |
| SCHEMBL29499924 | 0.89 | PRKCA (0.41) | PRKCATK2 | |
| SCHEMBL30190242 | 0.89 | PRKCA (0.41) | PRKCATK2 | |
| SCHEMBL3887099 | 0.89 | PRKCA (0.41) | PRKCATK2 | |
| SCHEMBL3889152 | 0.89 | PRKCA (0.41) | PRKCATK2 | |
| SCHEMBL285222 | 0.83 | PRKCA (0.41) | PRKCA | |
| SCHEMBL29361715 | 0.81 | TLR4 (0.40) | — | |
| SCHEMBL8349040 | 0.80 | PRKCA (0.45) | PRKCA | |
| SCHEMBL1132095 | 0.80 | PRKCA (0.45) | PRKCA | |
| SCHEMBL4651489 | 0.79 | PRKCA (0.44) | PRKCATK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1796 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260144726-A1 | POLYOL-FREE COSMETIC COMPOSITION COMPRISING ALPHA HYDROXY ACID ESTER | L'OREAL (FR) | 2026-05-28 | — | — | US | claimed |
| EP-4554379-B1 | USE OF AN ALKANEDIOL AS HERBICIDE | APEO AGRONOMICAL PLANT EXTRACTS & ESSENTIAL OILS (BE) | 2026-05-27 | — | — | EP | claimed |
| EP-4743052-A1 | 3-HYDROXYPROPYLESTERS AS EMULSIFYING AGENTS | Symrise AG (DE) | 2026-05-20 | — | — | EP | claimed |
| US-20260068876-A1 | COMPOSITION | Aspire Technology Group Ltd (GB) | 2026-03-12 | — | — | US | claimed |
| US-20260068877-A1 | COMPOSITION | Aspire Technology Group Ltd (GB) | 2026-03-12 | — | — | US | claimed |
| US-20260068878-A1 | COMPOSITION | Aspire Technology Group Ltd (GB) | 2026-03-12 | — | — | US | claimed |
| EP-4687813-A1 | COSMETIC EMULSION WITH REDUCED WHITE FOAMING | Beiersdorf AG (DE) | 2026-02-11 | — | — | EP | claimed |
| EP-4661853-A1 | LIPID NANOPARTICLES FOR THE TREATMENT OF OCULAR DISEASES | Universitat de Barcelona (ES) | 2025-12-17 | — | — | EP | claimed |
| US-20250360064-A1 | COMPOSITIONS AND METHODS FOR MOISTURIZING A SKIN REGION | JAMRM LLC (US) | 2025-11-27 | — | — | US | claimed |
| EP-4642418-A1 | FORMULATIONS AND METHODS FOR SKIN CARE OR HYALURONIC ACID SYNTHESIS | AmiLyfe, LLC (US) | 2025-11-05 | — | — | EP | claimed |
| CN-114126572-A | Coating composition | 科蒂公司 | 2022-03-01 | — | — | CN | claimed |
| EP-3956079-A1 | LUBRICIOUS SURFACES, SYSTEMS AND METHODS FOR MAKING THE SAME | Liquiglide Inc. (US) | 2022-02-23 | — | — | EP | claimed |
| EP-3955894-A1 | SELF-EMULSIFYING DRUG DELIVERY SYSTEMS FOR DELIVERY OF LIPOPHILIC COMPOUNDS | Yissum Research Development Company of the Hebrew University of Jerusalem Ltd (IL) | 2022-02-23 | — | — | EP | claimed |
| CN-114080215-A | Elastomeric liposome composition comprising sucrose-based surfactant and cosmetic composition containing the same | 韩国科玛株式会社 | 2022-02-22 | — | — | CN | claimed |
| WO-2022034992-A1 | LIPOSOME COMPLEX AND COSMETIC COMPOSITION FOR SKIN IMPROVEMENT COMPRISING SAME | 한국콜마 주식회사 | 2022-02-17 | — | — | WO | claimed |
| WO-2022029147-A1 | COSMETIC COMPOSITION COMPRISING CAPSULES | GIVAUDAN SA (CH) | 2022-02-10 | — | — | WO | claimed |
| US-11241373-B2 | Cosmetic composition of dispersion formulation comprising spherical particle | AMOREPACIFIC CORPORATION (KR) | 2022-02-08 | — | — | US | claimed |
| US-20220032330-A1 | VARIABLE DOSE CONTAINER | HALEON US HOLDINGS LLC | 2022-02-03 | — | — | US | claimed |
| EP-3943071-A1 | COMPOSITION COMPRISING NATURAL LIPOPHILIC COMPOUNDS, USE OF THE COMPOSITION AND METHOD FOR PREPARING THE COMPOSITION | Khinikadze, Zurab Durmischchanowitch (RU) | 2022-01-26 | — | — | EP | claimed |
| CN-113966213-A | Self-emulsifying drug delivery system for delivery of lipophilic compounds | 耶路撒冷希伯来大学伊森姆研究发展有限公司 | 2022-01-21 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260068878-A1 | COMPOSITION | SCD, SORD, SCD5 | PRKCA 1984/4885TK2 3905/4885 |
| US-20260144726-A1 | POLYOL-FREE COSMETIC COMPOSITION COMPRISING ALPHA HYDROXY ACID ESTER | HAO2, HADH, LDHA | PRKCA 1015/4885TK2 654/4885 |
| US-20260068876-A1 | COMPOSITION | SCD, DGKG, SCD5 | PRKCA 241/4885TK2 3567/4885 |
| US-20260068877-A1 | COMPOSITION | SCD, SORD, CD44 | PRKCA 1425/4885TK2 3396/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.